Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AbbVie Maintains US Humira Erosion Belief As 2023 Negotiations Near
Originator Has Previously Outlined 45% Erosion ‘Plus-Or-Minus 10%’
Jan 13 2022
•
By
Dean Rudge
Evercore: Humira is in a strong formulary position • Source: Alexander Sánchez / Alamy Stock Photo
More from Biosimilars
More from Products